NO20006455D0 - Testosteron-derivat - Google Patents

Testosteron-derivat

Info

Publication number
NO20006455D0
NO20006455D0 NO20006455A NO20006455A NO20006455D0 NO 20006455 D0 NO20006455 D0 NO 20006455D0 NO 20006455 A NO20006455 A NO 20006455A NO 20006455 A NO20006455 A NO 20006455A NO 20006455 D0 NO20006455 D0 NO 20006455D0
Authority
NO
Norway
Prior art keywords
testosterone
compound
testosterone derivative
good
oxoundecyl
Prior art date
Application number
NO20006455A
Other languages
English (en)
Other versions
NO316518B1 (no
NO20006455L (no
Inventor
Dirk Leysen
Hendrikus Adrianus Anton Voort
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20006455L publication Critical patent/NO20006455L/no
Publication of NO20006455D0 publication Critical patent/NO20006455D0/no
Publication of NO316518B1 publication Critical patent/NO316518B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20006455A 1998-06-19 2000-12-18 Testosteron-derivat NO316518B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en) 1998-06-19 1999-06-14 Testosterone derivative

Publications (3)

Publication Number Publication Date
NO20006455L NO20006455L (no) 2000-12-18
NO20006455D0 true NO20006455D0 (no) 2000-12-18
NO316518B1 NO316518B1 (no) 2004-02-02

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006455A NO316518B1 (no) 1998-06-19 2000-12-18 Testosteron-derivat

Country Status (26)

Country Link
US (3) US6437158B1 (no)
EP (1) EP1087986B1 (no)
JP (1) JP2002518514A (no)
KR (1) KR100596649B1 (no)
CN (1) CN1172949C (no)
AT (1) ATE215961T1 (no)
AU (1) AU756739B2 (no)
BR (1) BR9911344A (no)
CA (1) CA2333985C (no)
CZ (1) CZ293319B6 (no)
DE (1) DE69901250T2 (no)
DK (1) DK1087986T3 (no)
ES (1) ES2175989T3 (no)
HK (1) HK1034263A1 (no)
HU (1) HUP0102274A3 (no)
ID (1) ID27260A (no)
IL (1) IL139689A (no)
NO (1) NO316518B1 (no)
NZ (1) NZ508299A (no)
PL (1) PL191285B1 (no)
PT (1) PT1087986E (no)
RU (1) RU2216546C2 (no)
SK (1) SK282796B6 (no)
TR (1) TR200003743T2 (no)
WO (1) WO1999067271A1 (no)
ZA (1) ZA200006813B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
ATE294812T1 (de) * 2000-07-28 2005-05-15 Akzo Nobel Nv 16alpha-methyl oder ethyl substituierte oestrogene
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
CN104487114A (zh) * 2012-04-06 2015-04-01 安塔雷斯药品公司 针头辅助喷射注射给予睾酮组合物
EP2953667B1 (en) 2013-02-11 2019-10-23 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
IL139689A0 (en) 2002-02-10
AU4610199A (en) 2000-01-10
NO316518B1 (no) 2004-02-02
SK282796B6 (sk) 2002-12-03
RU2216546C2 (ru) 2003-11-20
US6437158B1 (en) 2002-08-20
KR20010052850A (ko) 2001-06-25
BR9911344A (pt) 2001-03-13
CZ20004779A3 (en) 2001-06-13
HK1034263A1 (en) 2001-10-19
AU756739B2 (en) 2003-01-23
NO20006455L (no) 2000-12-18
WO1999067271A1 (en) 1999-12-29
DK1087986T3 (da) 2002-06-17
KR100596649B1 (ko) 2006-07-06
SK19402000A3 (sk) 2001-07-10
US20040033999A1 (en) 2004-02-19
ATE215961T1 (de) 2002-04-15
JP2002518514A (ja) 2002-06-25
CA2333985A1 (en) 1999-12-29
HUP0102274A3 (en) 2002-08-28
HUP0102274A2 (hu) 2001-12-28
ES2175989T3 (es) 2002-11-16
CN1172949C (zh) 2004-10-27
US6989378B2 (en) 2006-01-24
EP1087986B1 (en) 2002-04-10
PT1087986E (pt) 2002-08-30
PL344987A1 (en) 2001-11-19
TR200003743T2 (tr) 2001-07-23
DE69901250D1 (de) 2002-05-16
ZA200006813B (en) 2002-02-21
CN1305488A (zh) 2001-07-25
IL139689A (en) 2004-09-27
CA2333985C (en) 2007-04-10
CZ293319B6 (cs) 2004-04-14
DE69901250T2 (de) 2002-10-17
EP1087986A1 (en) 2001-04-04
US20050153949A1 (en) 2005-07-14
ID27260A (id) 2001-03-22
NZ508299A (en) 2003-04-29
PL191285B1 (pl) 2006-04-28

Similar Documents

Publication Publication Date Title
DK1087986T3 (da) Testosteronderivat
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
EA200300337A1 (ru) Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
AU2610699A (en) Derivatives of glp-1 analogs
MXPA05009985A (es) Ligandos de receptores de canabinoides.
ES2134847T3 (es) Derivados de taxol.
HK1082258A1 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
BR0109703A (pt) Derivados de piperazina
DE60135748D1 (de) Synthese zyklischerverbindungen
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
DE69617909T2 (de) 2-substituierte vitamin-d3-derivate
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
AR018888A1 (es) Un derivado de testosterona, uso del mismo, una formulacion farmaceutica que comprende a dicho derivado y un kit para la anticoncepcion masculina
EP1270567A4 (en) PYRAZOLINE DERIVATIVES OR TETRAHYDROPYRAZOLINE DERIVATIVES AND THEIR MEDICAL USE
BR0013100A (pt) Processo para a preparação de um composto de 2-arilvinil alquil éter
ECSP992934A (es) Procedimiento mejorado para la preparacion de derivados de norbenzomorfano, valiosos farmaceuticamente